학술논문

Comparative immunogenicity and safety of SpikoGen®, a recombinant SARS-CoV-2 spike protein vaccine in children and young adults: An immuno-bridging clinical trial
Document Type
Article
Source
In: International Immunopharmacology. (International Immunopharmacology, 25 January 2024, 127)
Subject
Language
English
ISSN
18781705
15675769